Fusion Pharmaceuticals Inc
(FUSN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -54,955 | -10,222 | -16,189 | -7,983 | -7,389 |
| Depreciation Amortization | 270 | 172 | 290 | 213 | 134 |
| Income taxes - deferred | N/A | N/A | -59 | N/A | N/A |
| Accounts payable and accrued liabilities | -319 | 858 | 479 | 408 | -12 |
| Other Working Capital | 949 | 614 | 3,085 | 1,294 | 458 |
| Other Operating Activity | 40,238 | 958 | -1,296 | -3,789 | -20 |
| Operating Cash Flow | $-13,817 | $-7,620 | $-13,690 | $-9,857 | $-6,829 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -382 | -214 | -456 | -340 | -151 |
| Investing Cash Flow | $-382 | $-214 | $-456 | $-340 | $-151 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 197,625 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 70,122 | 9,907 | 52,187 | 52,187 | 52,187 |
| Financing Cash Flow | $267,747 | $9,907 | $52,187 | $52,187 | $52,187 |
| Beginning Cash Position | 67,121 | 67,121 | 29,080 | 29,080 | 29,080 |
| End Cash Position | 320,669 | 69,194 | 67,121 | 71,070 | 74,287 |
| Net Cash Flow | $253,548 | $2,073 | $38,041 | $41,990 | $45,207 |
| Free Cash Flow | |||||
| Operating Cash Flow | -13,817 | -7,620 | -13,690 | -9,857 | -6,829 |
| Capital Expenditure | -382 | -214 | -456 | -340 | -151 |
| Free Cash Flow | -14,199 | -7,834 | -14,146 | -10,197 | -6,980 |